OTC Markets OTCPK - Delayed Quote USD

Medican Enterprises, Inc. (MDCN)

Compare
0.0000 0.0000 (0.00%)
As of November 20 at 3:00 PM EST. Market Open.
Loading Chart for MDCN
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask 0.0001 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0001
  • Volume 3,996,996
  • Avg. Volume 0
  • Market Cap (intraday) 389,450
  • Beta (5Y Monthly) 97.68
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.

www.medicaninc.com

3

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MDCN

View More

Performance Overview: MDCN

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MDCN
0.00%
S&P 500
23.91%

1-Year Return

MDCN
0.00%
S&P 500
29.97%

3-Year Return

MDCN
96.67%
S&P 500
25.81%

5-Year Return

MDCN
90.00%
S&P 500
90.14%

Compare To: MDCN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDCN

View More

Valuation Measures

Annual
As of 10/24/2024
  • Market Cap

    389.45k

  • Enterprise Value

    389.45k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -6,818.39%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -134.8M

  • Diluted EPS (ttm)

    -0.3900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.4k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    194.25k

Research Analysis: MDCN

View More

Company Insights: MDCN

Research Reports: MDCN

View More

People Also Watch